糖尿病足潰瘍治療市場－全球產業規模、佔有率、趨勢、機會和預測（按治療、潰瘍類型、最終用戶、地區和競爭細分，2020-2030 年）

2024 年全球糖尿病足潰瘍治療市場價值為 55.1 億美元，預計到 2030 年將達到 84.8 億美元，預測期內的複合年成長率為 7.45%。全球糖尿病足潰瘍治療市場正經歷顯著成長，這得益於久坐不動的生活方式和不健康的飲食習慣的日益盛行。此外，對低成本無痛治療的需求不斷成長，加上人們美學意識的不斷增強，顯著增加了全球不同地區對糖尿病足潰瘍治療的需求。此外，全球老齡人口不斷成長，容易患上足潰瘍等不同類型的潰瘍疾病，預計這將進一步增加對不同牙齒輪廓整形手術的需求，從而推動市場成長。此外，由於全球不健康的生活方式導致肥胖症盛行率不斷上升，預計也將在預測期內支持糖尿病足潰瘍治療市場。

此外，預計適當醫療設備和藥物的使用將進一步增加對糖尿病足潰瘍治療的需求，從而支持市場成長。根據美國疾病管制與預防中心 (CDC) 的數據，美國有 600 萬 18 歲及以上人口患有糖尿病前期，2,640 萬 65 歲及以上人口（48.8%）患有糖尿病前期。

關鍵市場促進因素

全球糖尿病盛行率上升

主要市場挑戰

發展中地區的高成本和有限的報銷

主要市場趨勢

遠距醫療與遠距傷口監測的整合

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球糖尿病足潰瘍治療市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依治療（傷口照護敷料、生物製劑、治療設備、抗生素藥物、其他）
  • 依潰瘍類型（神經性潰瘍、缺血性潰瘍、神經缺血性潰瘍）
  • 按最終使用者（醫院和診所、門診護理中心、其他）
  • 按地區
  • 按公司分類（2024）
• 市場地圖
  • 按治療
  • 按潰瘍類型
  • 按最終用戶
  • 按地區

第6章：北美糖尿病足潰瘍治療市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲糖尿病足潰瘍治療市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 法國
  • 德國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太糖尿病足潰瘍治療市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：南美洲糖尿病足潰瘍治療市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第10章：中東與非洲糖尿病足潰瘍治療市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 最新動態
• 併購
• 產品發布

第 13 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品/服務的威脅

第 14 章：SWOT 分析：全球糖尿病足潰瘍治療市場

第 15 章：競爭格局

• 3M Company
• Medtronic Plc
• ConvaTec, Inc.
• Coloplast Corporation
• Smith & Nephew Plc
• B Braun Melsungen AG
• Medline Industries, Inc.
• Organogenesis, Inc.
• Molnlycke Health Care AB
• Acelity LP, Inc.

第 16 章：策略建議

第17章調查會社について,免責事項

Global Diabetic Foot Ulcer Treatment Market was valued at USD 5.51 billion in 2024 and is expected to reach USD 8.48 billion by 2030 with a CAGR of 7.45% during the forecast period. The global market for Diabetic Foot Ulcer Treatment is experiencing significant growth, driven by the increasingly leading of sedentary lifestyle along with consuming unhealthy food habits. Additionally, the growing demand for painless treatment with low cost coupled with increasing aesthetic consciousness among the population has significantly increased the demand for diabetic foot ulcer treatment across different parts of the globe. Additionally, the growing aging population across the globe which is susceptible to different kinds of ulcer diseases like foot ulcers is further expected to increase the demand for different dental contouring procedures, thereby fuelling market growth. Besides, the growing prevalence of obesity because of leading unhealthy lifestyles across the globe is further expected to support the diabetic foot ulcer treatment market during the forecast period.

Furthermore, the growing usage of proper medical equipment and medicines is further expected to increase the demand for diabetic foot ulcer treatment, thereby supporting market growth. According to the Centers for Disease Control and Prevention (CDC), 6 million people aged 18 years or older have prediabetes in the United States and 26.4 million people aged 65 years or older (48.8%) have prediabetes.

Key Market Drivers

Rising Global Prevalence of Diabetes

One of the most significant drivers of the diabetic foot ulcer treatment market is the alarming rise in global diabetes prevalence. Diabetic foot ulcers are among the most serious complications of uncontrolled diabetes and often result in infection, hospitalization, or amputation if not properly managed. According to the International Diabetes Federation (IDF), approximately 537 million adults worldwide were living with diabetes in 2021-a figure projected to rise to 783 million by 2045. A significant proportion of these individuals are at risk of developing foot ulcers at some stage due to peripheral neuropathy and vascular complications.

In response, national healthcare systems are actively scaling up preventive treatment strategies for diabetic complications. For instance, the Centers for Disease Control and Prevention (CDC) in the U.S. estimates that 15% of diabetic patients develop foot ulcers, and up to 25% may eventually require amputation if untreated. Many countries, including India, China, and Brazil-where diabetes rates are surging-have launched national diabetes control programs focusing on early detection and comprehensive wound care.

The growing diabetic population has led to an increase in the demand for advanced wound care products, offloading devices, and surgical interventions. Government-supported reimbursements for chronic wound management in public health systems across Europe and North America also encourage greater access to treatment. As a result, the diabetic foot ulcer treatment market is experiencing continuous growth due to the expanding patient base and escalating need for long-term management solutions.

Key Market Challenges

High Cost and Limited Reimbursement in Developing Regions

One of the key challenges impeding the growth of the DFU treatment market is the high cost of advanced wound care solutions, particularly in low- and middle-income countries (LMICs). Treatments such as NPWT, skin grafts, bioengineered skin substitutes, and HBOT often require specialized equipment and trained personnel, making them unaffordable for many patients. Unlike high-income countries, where public health systems cover most costs, LMICs often lack comprehensive insurance schemes that include chronic wound care. According to the World Bank, more than half the world's population lacks access to essential healthcare services, and out-of-pocket healthcare expenses push approximately 100 million people into extreme poverty annually. This financial barrier makes it challenging for many diabetic patients to pursue prolonged ulcer care, leading to complications and avoidable amputations.

Key Market Trends

Integration of Telemedicine and Remote Wound Monitoring

With the digital transformation of healthcare, telemedicine is emerging as a vital trend in diabetic foot ulcer treatment. Patients with DFUs often require frequent assessments to monitor wound progression, detect signs of infection, and adjust treatment plans. In rural or underserved areas, access to wound care specialists is limited, making telehealth a critical tool for continuous care. Governments are increasingly recognizing the potential of digital health solutions. For example, the U.S. Health Resources and Services Administration (HRSA) and similar agencies in Europe have expanded funding for remote chronic care management tools, including wound imaging apps and digital platforms that allow clinicians to evaluate ulcers remotely. These technologies enable early detection of complications, improve patient compliance, and reduce the need for hospital visits.

In countries like Australia and Canada, telemedicine platforms are being used to connect patients in remote regions with urban wound care centers, ensuring equitable access to expertise. Some platforms use AI to assess wound size, depth, and tissue characteristics, supporting data-driven treatment decisions. Furthermore, digital recordkeeping and remote prescriptions simplify follow-ups and allow multidisciplinary teams to coordinate care more effectively. As global digital health adoption grows, integrating wound care into telemedicine ecosystems will be an important advancement in improving treatment outcomes and patient satisfaction for DFUs.

Key Market Players

• 3M Company
• Medtronic Plc
• ConvaTec, Inc.
• Coloplast Corporation
• Smith & Nephew Plc
• B Braun Melsungen AG
• Medline Industries, Inc.
• Organogenesis, Inc.
• Molnlycke Health Care AB
• Acelity L.P., Inc.

Report Scope:

In this report, the Global Diabetic Foot Ulcer Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Diabetic Foot Ulcer Treatment Market, By Treatment:

• Wound Care Dressings
• Biologics
• Therapy Devices
• Antibiotic Medications
• Others

Diabetic Foot Ulcer Treatment Market, By Ulcer Type:

• Neuropathic Ulcers
• Ischemic Ulcers
• Neuroischemic Ulcers

Diabetic Foot Ulcer Treatment Market, By End User:

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Diabetic Foot Ulcer Treatment Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Diabetic Foot Ulcer Treatment Market.

Available Customizations:

Global Diabetic Foot Ulcer Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Diabetic Foot Ulcer Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Treatment (Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications, Others)
  • 5.2.2. By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, Neuroischemic Ulcers)
  • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map
  • 5.3.1. By Treatment
  • 5.3.2. By Ulcer Type
  • 5.3.3. By End User
  • 5.3.4. By Region

6. North America Diabetic Foot Ulcer Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Treatment
  • 6.2.2. By Ulcer Type
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Diabetic Foot Ulcer Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Treatment
      • 6.3.1.2.2. By Ulcer Type
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Diabetic Foot Ulcer Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Treatment
      • 6.3.2.2.2. By Ulcer Type
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Diabetic Foot Ulcer Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Treatment
      • 6.3.3.2.2. By Ulcer Type
      • 6.3.3.2.3. By End User

7. Europe Diabetic Foot Ulcer Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Treatment
  • 7.2.2. By Ulcer Type
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Diabetic Foot Ulcer Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Treatment
      • 7.3.1.2.2. By Ulcer Type
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Diabetic Foot Ulcer Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Treatment
      • 7.3.2.2.2. By Ulcer Type
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Diabetic Foot Ulcer Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Treatment
      • 7.3.3.2.2. By Ulcer Type
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Diabetic Foot Ulcer Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Treatment
      • 7.3.4.2.2. By Ulcer Type
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Diabetic Foot Ulcer Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Treatment
      • 7.3.5.2.2. By Ulcer Type
      • 7.3.5.2.3. By End User

8. Asia-Pacific Diabetic Foot Ulcer Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Treatment
  • 8.2.2. By Ulcer Type
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Diabetic Foot Ulcer Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Treatment
      • 8.3.1.2.2. By Ulcer Type
      • 8.3.1.2.3. By End User
  • 8.3.2. India Diabetic Foot Ulcer Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Treatment
      • 8.3.2.2.2. By Ulcer Type
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Diabetic Foot Ulcer Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Treatment
      • 8.3.3.2.2. By Ulcer Type
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Diabetic Foot Ulcer Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Treatment
      • 8.3.4.2.2. By Ulcer Type
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Diabetic Foot Ulcer Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Treatment
      • 8.3.5.2.2. By Ulcer Type
      • 8.3.5.2.3. By End User

9. South America Diabetic Foot Ulcer Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Treatment
  • 9.2.2. By Ulcer Type
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Diabetic Foot Ulcer Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Treatment
      • 9.3.1.2.2. By Ulcer Type
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Diabetic Foot Ulcer Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Treatment
      • 9.3.2.2.2. By Ulcer Type
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Diabetic Foot Ulcer Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Treatment
      • 9.3.3.2.2. By Ulcer Type
      • 9.3.3.2.3. By End User

10. Middle East and Africa Diabetic Foot Ulcer Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Treatment
  • 10.2.2. By Ulcer Type
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Diabetic Foot Ulcer Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Treatment
      • 10.3.1.2.2. By Ulcer Type
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Diabetic Foot Ulcer Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Treatment
      • 10.3.2.2.2. By Ulcer Type
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Diabetic Foot Ulcer Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Treatment
      • 10.3.3.2.2. By Ulcer Type
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products/Services

14. SWOT Analysis: Global Diabetic Foot Ulcer Treatment Market

15. Competitive Landscape

• 15.1. 3M Company
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Medtronic Plc
• 15.3. ConvaTec, Inc.
• 15.4. Coloplast Corporation
• 15.5. Smith & Nephew Plc
• 15.6. B Braun Melsungen AG
• 15.7. Medline Industries, Inc.
• 15.8. Organogenesis, Inc.
• 15.9. Molnlycke Health Care AB
• 15.10. Acelity L.P., Inc.

16. Strategic Recommendations

17. About Us & Disclaimer